ornidazole has been researched along with ciprofloxacin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Charbit, Y; Fosse, TB; Hannoun, LR; Hitzig, C; Madinier, IM | 1 |
| Inceboz, T; Inceboz, U; Ozturk, S | 1 |
| Das, D; Dhara, S; Ghosh, P; Pal, S; Panda, AB | 1 |
| Das, D; Dhara, S; Ghosh, A; Ghosh, P; Haldar, C; Pal, S; Panda, AB | 1 |
| Büker, E; Dinç, E; Ertekin, ZC | 1 |
| Bulbul, S; Karakaya, D; Tunca, AK | 1 |
7 other study(ies) available for ornidazole and ciprofloxacin
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Resistance profile survey of 50 periodontal strains of Actinobacillus actinomyectomcomitans.
Topics: Adult; Aggregatibacter actinomycetemcomitans; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Ciprofloxacin; Drug Resistance, Microbial; Erythromycin; Humans; Metronidazole; Microbial Sensitivity Tests; Ornidazole; Periodontal Pocket; Periodontitis; Species Specificity; Spiramycin; Tetracycline; Virginiamycin | 1999 |
Comparative in vitro cytotoxic effects of ornidazole, metronidazole and ciprofloxacin against Trichomonas vaginalis trophozoites.
Topics: Animals; Antitrichomonal Agents; Ciprofloxacin; Female; Humans; Metronidazole; Ornidazole; Parasitic Sensitivity Tests; Trichomonas vaginalis; Trichomonas Vaginitis | 2004 |
Dextrin and poly(acrylic acid)-based biodegradable, non-cytotoxic, chemically cross-linked hydrogel for sustained release of ornidazole and ciprofloxacin.
Topics: Acrylic Resins; Biocompatible Materials; Ciprofloxacin; Dextrins; Drug Carriers; Drug Liberation; Hydrogels; Hydrogen-Ion Concentration; Kinetics; Muramidase; Ornidazole; Rheology; Tablets; Temperature | 2015 |
Stimulus-Responsive, Biodegradable, Biocompatible, Covalently Cross-Linked Hydrogel Based on Dextrin and Poly(N-isopropylacrylamide) for in Vitro/in Vivo Controlled Drug Release.
Topics: Acrylic Resins; Animals; Biocompatible Materials; Cell Proliferation; Cell Survival; Ciprofloxacin; Delayed-Action Preparations; Dextrins; Drug Carriers; Hydrogel, Polyethylene Glycol Dimethacrylate; Mesenchymal Stem Cells; Ornidazole; Rabbits; Tissue Engineering | 2015 |
Two-way and three-way approaches to ultra high performance liquid chromatography-photodiode array dataset for the quantitative resolution of a two-component mixture containing ciprofloxacin and ornidazole.
Topics: Calibration; Chromatography, High Pressure Liquid; Ciprofloxacin; Ornidazole; Tablets | 2016 |
Developing and validation of impurity and the simultaneous quantity determination methods for tablet forms containing Ciprofloxacin HCl and Ornidazole.
Topics: Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Ciprofloxacin; Drug Combinations; Drug Contamination; Limit of Detection; Ornidazole; Reproducibility of Results; Tablets | 2020 |